Novartis Investigative Site

Apeldoorn, DZ 7334

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Breast Cancer, Cardiovascular Disease and Lipoprotein(a), Heart Failure With Preserved Ejection Fraction

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed